We thus assessed the incidence of pGF post 8–10/10 HLA-matched UD-HSCT with PTCy in patients with AML using the registry data of the ALWP of the European Society for Blood and Marrow Transplantation (EBMT). The gene discussed is PGF; the disease is acute myeloid leukemia.